openPR Logo
Press release

Global Endometriosis Market Research and Forecast 2018-2023

07-02-2018 03:41 PM CET | Health & Medicine

Press release from: Orion Market Research

Global Endometriosis Market Research and Forecast 2018-2023

Endometriosis is a painful disorder in which the layer of tissue that normally surfaces inside the uterus, starts growing outside the uterus. This mainly occurs on the fallopian tubes, ovaries, and tissue around the uterus; however, in exceptional cases it may occur in other parts of the body. The endometriosis leads to various physical symptoms such as severe menstrual cramps, nausea and vomiting, fatigue, diarrhea, constipation, long-term pelvic pain, and periods lasting over 7 days, among others. Moreover, the impending treatment of endometriosis market may lead to infertility, formation of ovarian cysts, inflammation, and scar tissue and adhesion development, among others. According to endometriosis.org, the disorder affects an approximately of one in 10 women during their reproductive years, estimating to around 176 million women in the world.

Increasing female population of the reproductive age and growing awareness rate of the disease are some of the factors significantly contributing towards the growth of the global endometriosis market. High investment made by the government in the R&D of endometriosis disorder, so as to introduce enhanced medical treatment is fueling the market growth. Moreover, growing prevalence of endometriosis across the globe is leading to the expansion of product portfolio by major market players in the endometriosis market. However, high cost of advanced therapeutic drugs, high investment required for the R&D of novel drugs, and time required for the diagnosing of the disease are some of the factors hampering the growth of the global endometriosis market.

Browse full report at: https://www.omrglobal.com/industry-reports/endometriosis-market/

The endometriosis market can be segmented on the basis of drug type, diagnosis type, treatment type, and distribution channel. Based on drug type, the market is segmented into gonadotropins releasing hormone agonists, non-steroidal anti-inflammatory drugs, progestin, and oral contraceptive pills. Based on diagnosis type, the market is bifurcated into ultrasound, pelvic exam, laparoscopy, magnetic resonance imaging (MRI), hysteroscopy, and sonohysterography. Based on treatment type, the market is segmented into hormonal therapy and pain management. Based on distribution channel, the market is diversified into hospital pharmacies, drug stores, retail pharmacies, mail order pharmacies, and e-commerce.

The global endometriosis market is further analyzed on the basis of the geographical regions that are contributing significantly towards the growth of the market. North America holds a dominant position in the global endometriosis market and is expected to retain its position over the forecast period. This is mainly owing to large number of female population suffering from endometriosis in the region. Moreover, increasing spending on R&D by the government in the treatment of endometriosis and endometrial cancer is another factor fueling growth of the endometriosis market in the region.

Related Reports: https://www.omrglobal.com/reports-category/healthcare/

https://www.omrglobal.com/reports-category/pharmaceuticals/

Some of the key vendors of the endometriosis market are Abbott, AbbVie Inc., Bayer AG, Ipsen, Myovant Sciences Ltd., Pfizer, Inc., Philogen, Astellas Pharma, Orphagen Pharmaceuticals, Inc., and Meditrina Pharmaceuticals, among others. In order to sustain in the competitive market, these players adopt various strategies such as acquisitions, mergers, expansions, joint ventures, and product development and so on. For instance, in March 2018, Astellas Pharma announced the development of Opigolix (ASP 1707), a luteinizing-hormone-releasing hormone receptor antagonist. The product can be used for the oral treatment of endometriosis.

Some Brief Table of Contents of Report

CHAPTER 1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN

CHAPTER 2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST INSIGHT & CURRENT MARKET TRENDs
2.3. REGULATIONS

CHAPTER 3. MARKET DETERMINANT
3.1. MOTIVATORS
3.2. RESTRAINTS
3.3. OPPORTUNITIES

CHAPTER 4. MARKET SEGMENTATION
4.1. GLOBAL ENDOMETRIOSIS MARKET, BY DRUG TYPE
4.2. GLOBAL ENDOMETRIOSIS MARKET, BY DIAGNOSIS TYPE
4.3. GLOBAL ENDOMETRIOSIS MARKET, BY TREATMENT TYPE
4.4. GLOBAL ENDOMETRIOSIS MARKET BY DISTRIBUTION CHANNEL

TOC Continued…

For More Updates Follow LinkedIn: www.linkedin.com/company/omr-global-research/

About Orion Market Research

OMR is a market research company known for its qualitative and quantitative research reports. The company aims to provide business insights for decision making to our global clients. OMR provides syndicated and customized research reports, company profiling, consulting and other research-based services to global clients. At OMR, we believe in overcoming the competition by delivering quality reports on time.

CORPORATE OFFICE:

Orion Market Research Pvt Ltd
116, Shagun Arcade, Vijay Nagar Square
Indore – India- 452010
Email: info@omrglobal.com, support@omrglobal.com
India: +91-780-304-0404, +91-917-982-8694
Global: +1-646-755-7667

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Endometriosis Market Research and Forecast 2018-2023 here

News-ID: 1104960 • Views: 587

More Releases from Orion Market Research

Germany COVID-19 Diagnostics Market Growth, Size, Share, Industry Report and For …
Germany COVID-19 diagnostics industry will see the considerable decline of 29.6% during the forecast period. A significant trend in the number of tests conducted in laboratories has been reported in the country. On June 03, 2020, Germany adopted its second economic-stimulus package since the start of the COVID-19 pandemic, which brings total support to $1.5 trillion, which is by far the largest in Europe as a share of GDP. This
France COVID-19 Diagnostics Market Size, Industry Trends, Share and Forecast 202 …
France's COVID-19 diagnostics market will see a considerable decline of 27.5% during the forecast period. COVID-19 testing has emerged rapidly in France owing to the surge in the daily COVID-19 incidences and government initiatives for free testing of coronavirus. On March 25, 2020, France Government declared that it would roll out a $4.33 billion liquidity support plan for start-ups amid coronavirus pandemics. On June 10, 2020, the government declared that
European COVID-19 Diagnostics Market Growth, Size, Share, Industry Report and Fo …
European COVID-19 diagnostics industry will see a considerable decline of 28.2% during the forecast period. Several projects for the development of COVID-19, diagnosis, and treatment were reported over the last few months in Europe. Additionally, on 22 July 2020, the European Commission declared nearly $117.8 million to co-fund a call for supporting R&D of coronavirus vaccines, and to develop diagnostic tests, treatments, and other prevention tools. This call was revealed
China COVID-19 Diagnostics Market Trends, Size, Competitive Analysis and Forecas …
China COVID-19 diagnostics market will see declined growth of 25.1% during the forecast period. China has a significant market share in the global COVID-19 diagnostic market owing to the growing number of diagnostic screening in the country coupled with government initiatives for providing rapid screening for COVID-19. Moreover, the introduction of advanced and early diagnostic tests in the country further propels the growth of the market. For instance, in February

All 5 Releases


More Releases for Endometriosis

Endometriosis Market Trends, Size, Forecast - 2018-2023
Endometriosis is a painful disorder in which the layer of tissue that normally surfaces inside the uterus, starts growing outside the uterus. This mainly occurs on the fallopian tubes, ovaries, and tissue around the uterus; however, in exceptional cases it may occur in other parts of the body. The endometriosis leads to various physical symptoms such as severe menstrual cramps, nausea and vomiting, fatigue, diarrhea, constipation, long-term pelvic pain, and
Global Endometriosis Treatment Market Insights, Forecast to 2025
Market Research Report Store offers a latest published report on Endometriosis Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 158 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/817758/global-endometriosis-treatment-market-insights   Therapies used to treat endometriosis include: Hormonal contraceptives. Birth
Endometriosis-Pipeline Review H2 2018
Endometriosis-Pipeline Review, H2 2018 Summary Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Endometriosis-Pipeline Review, H2 2018, provides an overview of the Endometriosis (Women's Health) pipeline landscape. Endometriosis is an often painful disorder in which tissue that normally lines the inside of uterus (endometrium) grows outside uterus (endometrial implant). Symptoms include pelvic pain, menstrual cramps, inflammation, infertility and abnormal bleeding. Risk factors age, uterine abnormalities, history of pelvic infection and family history. Treatment
Endometriosis Treatment Market Outlook, and Opportunity Analysis, 2018 – 2026
Endometriosis is a painful medical condition in which the tissue that lines in the inner part of the uterus i.e. endometrium grows outside the uterus. Endometriosis tissue is found in fallopian tubes, ovaries, and tissue lining the pelvis. In endometriosis, endometrial tissue which is displaced acts in the usual way i.e. it thickens, breaks down and eventually bleeds like in every menstrual cycle. As the displaced tissue has no other
Endometriosis Treatment Market Intelligence with Competitive Landscape 2024
Endometriosis is a medical condition in which the tissue that forms normal lining of uterus appears outside the uterus cavity and may involve ovaries, bowel, or tissue lining of the pelvic floor. This disease affects over 170 million women across the globe. Endometriosis has an unclear etiology and complex symptoms. Hence, the endometriosis treatment market is projected to grow substantially due to increase in number of cases for endometriosis and
Endometriosis Market to Register Substantial Expansion by 2018
Endometriosis is a medical condition in which the tissue that forms normal lining of uterus appears outside the uterus cavity and may involve ovaries, bowel or tissue lining of the pelvic floor. This disease affects over 170 million females across the globe. Endometriosis has an unclear etiology and complex symptoms. These factors contribute in difficulties for timely diagnosis and obstruct the drug discovery processes. Endometriosis is a major cause of